MarginsXMarginsX
Home › Markets › SLNCF

Silence Therapeutics plc (SLNCF)

SLNCF is quoted over the counter, not listed on an exchange. Silence Therapeutics plc files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 12, 2026
$6.53
No trades since Nov 12, 2026; later closes repeat the last quote
1-year return
+307.9%
Market cap
The company also trades on Nasdaq as SLN; this OTC line is another class or a foreign line, so its cap is not computed
P/E and P/S
Needs a market cap · Needs a market cap
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerSLNCF, quoted over the counter
SEC CIK0001479615
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressLondon
Incorporated inUnited Kingdom

Warning signs

Cash runway
67.3 months
$247.7M cash at September 30, 2026
Share count, 1 year
+31.7%
2025-10-30 to 2026-09-30 · +57.0% over 3 years
Going-concern doubt
No
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.
"As of September 30, 2026, the Group had cash and cash equivalents of $ 247.7 million. 9 Silence Therapeutics plc Notes to the Condensed Consolidated Financial Statements (Unaudited) - ( Continued ) In accordance with Accounting Standards Codification ("ASC") 205-40, Presentation of financial statements: Going concern, the Group has the responsibility to evaluate whether conditions and/or events raise substantial doub"
10-Q 2026-11-13
Cash and burn$247.7M cash; operating cash flow -$11.0M a quarter.Report 2026-09-30
Shares outstanding62,203,024 (2026-09-30); 47,233,949 a year earlier; 39,615,655 three years earlier.Cover page 2026-09-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 3 424B5 takedowns, 3 at the marketLatest 2026-08-12
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Reading, United KingdomPCAOB Form AP 2026-03-31
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$0-$12.4M-$12.8M$247.7MNo debt tags$456K10-Q 2026-11-13
Q2 2026
2026-06-30
$0-$12.3M$1.5M$72.1MNo debt tags$615K10-Q 2026-08-10
Q1 2026
2026-03-31
$422K-$15.0M-$15.6M$5.7MNo debt tags$839K10-Q 2026-05-07
Q4 2025
2025-12-31
$34K-$11.8M-$17.3M$11.3MNo debt tags$559K10-K 2026-03-05
Q3 2025
2025-09-30
$159K-$21.0M-$10.9M$82.0MNo debt tags$25.8M10-Q 2026-11-13
Q2 2025
2025-06-30
$224K-$27.4M-$21.8M$41.7MNo debt tags$27.2M10-Q 2026-08-10
Q1 2025
2025-03-31
$142K-$28.5M-$12.3M$64.9MNo debt tags$27.7M10-Q 2026-05-07
Q4 2024
2024-12-31
$25.3M$12.3M-$27.5M$121.3MNo debt tags$43.3M10-K 2026-03-05

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-08-12
Latest annual report10-K2026-03-05
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-12
Latest proxyDEFA14A2026-11-12

Source: SEC EDGAR submissions feed, 280 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier